CCL2 and breast carcinoma: IL-6 secreted by primary CAFs isolated from the tumor tissues of head and neck cancer (HNC) patients promoted HNC progression through the osteopontin-nuclear factor kappa B (NFκB) signaling pathway [18], whereas CCL2 produced by breast cancer primary CAFs promoted cancer advancement by regulating cancer stem cells through NOTCH activation [19].